APOA1 and alcoholic liver diseases: In addition, we also detected the expression of Apoa1, and the results showed that there was no statistical difference among the control group, the model group and the drug BA-treated group (Fig. 3F–H). The findings suggested that BA counteracted alcoholic liver damage by reducing lipid build up in the liver.